Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens

European Journal of Endocrinology

Volumn 142, Issue 1, 2000, Pages 79-83

  Abplanalp, W ^a   Scheiber, M D ^a   Moon, K ^a   Kessel, B ^b   Liu, J H ^a   Subbiah, M T R ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ESTERIFICATION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0033981643     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420079     Document Type: Article

References (25)

1. Bush TL. The epidemiology of cardiovascular disease in post-menopausal women. Annals of the New York Academy of Sciences 1990 592 263-271.
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B & Speizer FE. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses Health Study. New England Journal of Medicine 1991 325 756-762.
3. Barrett-Connor E & Bush TL. Estrogen and coronary heart disease in women. Journal of the American Medical Association 1991 256 1861-1867.
4. Stampfer MJ & Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Medicine 1991 20 47-63.
5. Seed M. Sex hormones, lipoproteins, and cardiovascular risk. Atherosclerosis 1991 90 1-7.
6. Bush TL, Barrett-Connor E, Cowan LD, Crique MH, Wallace RB, Suchiddran CM et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-Up Study. Circulation 1987 75 1002-1009.
7. Bush TL. Estrogen replacement and coronary artery disease: the primary and secondary prevention. Journal of Clinical Endocrinology and Metabolism 1996 81 3830-3832.
8. Subhiah MTR. Mechanisms of cardioprolection by estrogens. Proceedings of the Society for Experimental Biology and Medicine 1998 217 23-29.
9. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W & Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. Journal of Clinical Endocrinology and Metabolism 1993 77 1095-1097.
10. Rifici VA & Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism 1992 41 1110-1114.
11. Schwaery GT, Vita JA & Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol. Circulation 1997 95 1378-1385.
12. Tang M & Subbiah MTR. Estrogens protect against hydrogen peroxide and arachidonic acid induced DNA damage. Biochimica et Biophysica Acta 1996 1299 155-159.
13. Ayers S, Abplanalp W, Liu JH & Subbiah MTR. Mechanisms involved in the protective effect of estradiol-17β on lipid peroxidation and DNA damage. American Journal of Physiology 1998 274 (Endocrinology and Metabolism 37) E1002-E1008.
14. Sack MN, Rader DJ & Cannon RO. Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet 1994 343 269-270.
15. Guetta V, Lush RM, Figg WD, Waclawiw MA & Cannon RO. Effect of antiestrogen tamoxifen and conjugated estrogens on low density lipoprotein concentration and oxidation in postmenopausal women. Journal of the American College of Cardiology 1995 76 1072-1073.
16. Leszczynski DE & Schafer RM. Characterization of steroid hormone association with human plasma lipoproteins. Steroids 1989 54 37-53.
17. Leszczynski DE & Schafer RM. Metabolic conversion of six steroid hormones by human plasma high density lipoprotein. Biochimica et Biophysica Acta 1991 1083 18-28.
18. Junucko L & Hochberg RB. Estradiol fatty acid esters occur naturally in human blood. Science 1983 222 1334-1336.
19. Tang M, Abplanalp W & Subbiah MTR. Association of estrogens with human plasma lipoproteins. Journal of Laboratory and Clinical Medicine 1997 129 447-452.
20. Shweary GT, Vita GA & Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of estrogens is specific for 17β-estradiol. Atherosclerosis 1998 138 255-262.
21. Ayers S, Tang M & Subbiah MTR. Estradiol-17β as an antioxidant: some distinct features when compared with common fat soluble antioxidants. Journal of Laboratory and Clinical Medicine 1996 128 367-375.
22. Esterbauer H, Striegl H, Puhl H & Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989 6 67-75.
23. Pahuja SL & Hochberg RB. A comparison of the esterification of steroids by rat lecithin: cholesterol acyl transferase and acylcoenzymeA:cholesterol transferase. Endocrinology 1994 136 180-186.
24. Provost PR, Lavalee B & Belanger A. Transfer of dehydroepiandrosterone and pregnenalone-fatty acid esters between human lipoproteins. Journal of Clinical Endocrinology and Metabolism 1997 82 182-187.
25. Hochberg RB. Steroidal fatty acid esters. Journal of Steroid Biochemistry and Molecular Biology 1991 40 577-585.